Nu Skin Enterprises (NUS) Misses Q1 EPS by 1c; Eases FY15 EPS Outlook

Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.72, $0.01 worse than the analyst estimate of $0.73. Revenue for the quarter came in at $543.3 million versus the consensus estimate of $544.7 million.

Nu Skin Enterprises sees FY2015 EPS of $3.65-$3.75, versus the consensus of $3.95. Nu Skin Enterprises sees FY2015 revenue of $2.45-2.50 billion, versus the consensus of $2.53 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c